Search

News Release

Ault Appointed to Federal Immunization Committee

Kevin Ault, MD, member of The University of Kansas Cancer Center and professor and division director in the Department of Obstetrics and Gynecology, has been appointed to the Advisory Committee on Immunization Practices (ACIP) by Health and Human Ser...

News Release

CicloMed Announces FDA Clearance of IND Application for Ciclopirox Prodrug in the Treatment of Bladder Cancer

CicloMed LLC announced that its development candidate for non-muscle-invasive and muscle-invasive bladder cancer, Ciclopirox Prodrug, was cleared by the U.S. Food and Drug Administration to begin human clinical trials. With this clearance, CicloMed p...

News Release

Researchers identify metastasis-suppressing compound

A recent study has identified a compound that blocks the spread of cancer in mice in models of human prostate, pancreatic and breast cancer. Metastasis is the spread of cancerous tumors to other parts of the body, and it is the leading cause of cance...

News Release

Researchers Identify New Target for Treatment of Pancreatic Cancer

A preclinical study led by researchers at The University of Kansas Cancer Center has identified a region of the human genome, called a super-enhancer, as a novel target for a pancreatic cancer subtype called "pancreatic ductal adenocarcinoma" (PDAC)....

News Release

NCI-Designated Cancer Centers Endorse Goal of Eliminating HPV-Related Cancers

All National Cancer Institute (NCI)-designated cancer centers have fully endorsed the goal of eliminating cancers caused by HPV through genderneutral HPV vaccination and evidence-based cancer screening.

News Release

New Guidelines on Cervical Cancer Screening

New guidelines on cervical cancer screening from the U.S. Preventive Services Task Force published in JAMA.

News Release

Pilot Study Identifies Effects of Bazedoxifene and Conjugated Estrogen on Breast Cancer Risk Biomarkers in High Risk Women

Researchers at The University of Kansas Cancer Center have identified an agent that improves risk biomarkers for breast cancer while reducing menopausal side effects in women at increased risk for breast cancer. Chemoprevention drugs like tamoxifen...

News Release

Ciclomed Expands Fosciclopirox Phase 1 Trial to Include Cisplatin-Ineligible Muscle Invasive Bladder Cancer Patients

First patient enrolled at The University of Kansas Cancer Center in expansion cohort study characterizing the safety, pharmacokinetics and pharmacodynamics of fosciclopirox in bladder cancer patients. Kansas City, MO – December 4, 2019 – CicloMed LL...

News Release

Grant Advances Ovarian Cancer Early Detection Efforts

Researchers at The University of Kansas Cancer Center have received a three-year, $900,000 grant from the Ovarian Cancer Research Alliance (OCRA) to better understand why epithelial ovarian cancers take decades to develop as well as identify methods...